Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 31449468

Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2019 Oct 20
First author
Dix DB

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2020 Mar 1;38(7):772-773. doi: 10.1200/JCO.19.02479.
    note
    Source null
    related pmid
    31951492
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2020 Mar 1;38(7):773-774. doi: 10.1200/JCO.19.03113.
    note
    Source null
    related pmid
    31951494
    relationship
    Comment in

Authors and identifiers

  1. name
    Dix DB
    type
    Author
  2. name
    Fernandez CV
    type
    Author
  3. name
    Chi YY
    type
    Author
  4. name
    Mullen EA
    type
    Author
  5. name
    Geller JI
    type
    Author
  6. name
    Gratias EJ
    type
    Author
  7. name
    Khanna G
    type
    Author
  8. name
    Kalapurakal JA
    type
    Author
  9. name
    Perlman EJ
    type
    Author
  10. name
    Seibel NL
    type
    Author
  11. name
    Ehrlich PF
    type
    Author
  12. name
    Malogolowkin M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Dix DB
    type
    Author
  2. name
    Fernandez CV
    type
    Author
  3. name
    Chi YY
    type
    Author
  4. name
    Mullen EA
    type
    Author
  5. name
    Geller JI
    type
    Author
  6. name
    Gratias EJ
    type
    Author
  7. name
    Khanna G
    type
    Author
  8. name
    Kalapurakal JA
    type
    Author
  9. name
    Perlman EJ
    type
    Author
  10. name
    Seibel NL
    type
    Author
  11. name
    Ehrlich PF
    type
    Author
  12. name
    Malogolowkin M
    type
    Author
bibliography ids
  1. nci-bib-7b781157bad1008e92836ad7
book metadata
content sha256
9b3b2e201e10d3ad2f49532533c51e549d00449954d1ba860197e1efbec6d78f
document type
citation
dois
  1. 10.1200/JCO.18.01972
electronic publication date
display
2019 Aug 26
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31449468
immutable id
pubmed:31449468@9b3b2e201e10d3ad2f49532533c51e549d00449954d1ba860197e1efbec6d78f
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
30
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2769-2777
volume
37
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2020 Mar 1;38(7):772-773. doi: 10.1200/JCO.19.02479.
    note
    Source null
    related pmid
    31951492
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2020 Mar 1;38(7):773-774. doi: 10.1200/JCO.19.03113.
    note
    Source null
    related pmid
    31951494
    relationship
    Comment in
outcomes validated
false
pmid
31449468
provenance
batch id
23ffe1e2a9e160b6dca0
provider
NCBI PubMed ESummary
record sha256
a1aa88375630ca2f0eaaa875d82411f8f931480f632a29ece94dbba959ca10d4
response sha256
d5cbfde8f87ba85b214c53aaf0e8fa33d70fec48dd4fde7745538180cd7e1841
retrieved at
2026-09-09T23:47:44.690737+00:00
publication date
display
2019 Oct 20
precision
day
year
2019
publication types
  1. Journal Article
  2. Research Support, N.I.H., Extramural
  3. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31449468/
title
Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.

Preserved source evidence · Not medical advice